Table 4 Patient 72-h and 90-day outcomes by study phase
Study phase | 72-h follow-up | 90-day follow-up |
|---|---|---|
Pre-implementation (113 participants) | Alive 92/113 (81.4%) | Alive 47/113 (41.6%) |
Dead 8/113 (7.1%) | Dead 48/113 (42.5%) | |
Missing 13/113 (11.5%) | Missing 48/113 (42.5%) | |
Post-implementation (300 participants) | Alive 226/300 (75.3%) | Alive 61/300 (20.3%) |
Dead 65/300 (21.7%) | Dead 161/300 (53.7%) | |
Missing 9/300 (3.0%) | Missing 78/300 (26.0%) |